Article Information
History
- September 8, 2021.
Article Versions
- Version 1 (September 7, 2021 - 07:07).
- You are currently viewing Version 2 of this article (September 8, 2021 - 23:31).
- Version 3 (September 17, 2021 - 10:07).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tawanda Chivese1,*,
- Joshua T. Matizanadzo2,
- Omran A. H. Musa1,
- George Hindy1,
- Luis Furuya-Kanamori3,
- Nazmul Islam4,
- Rafal Al-Shebly1,
- Rana Shalaby1,
- Mohammad Habibullah1,
- Talal Al-Marwani1,
- Rizeq F Hourani1,
- Ahmed D Nawaz1,
- Mohammad Z Haider1,
- Mohamed M. Emara5,6,
- Farhan Cyprian5 and
- Suhail A. R. Doi1,*
- 1Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar
- 2Department of Public Health and Primary Care, Brighton and Sussex Medical School, United Kingdom
- 3UQ Centre for Clinical Research, The University of Queensland, Herston, Australia
- 4Department of Public Health, QU Health, Qatar University, Doha, Qatar
- 5Immunology section, Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar
- 6Microbiology section, Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar
- ↵*Corresponding authors Tawanda Chivese, Email: tchivese{at}qu.edu.qa, Suhail Doi, Email: sdoi{at}qu.edu.qa, Department of Population Medicine, College of medicine, QU Health, Qatar University, Doha, Qatar
Posted September 08, 2021.
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis of 12 011 447 individuals
